Study S000877

A 16-week Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of HRS-7535 in Adults With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT05759897
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: UNKNOWN
Enrollment: 180
Start: 2023-02-28
Primary completion: 2023-12-21
Lead sponsor: Shandong Suncadia Medicine Co., Ltd.
Conditions: Type 2 Diabetes
Interventions: DRUG:HRS-7535; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Mean Change From Baseline in HbA1c at Week 16 [at Week 16]]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0002101	HRS-7535 for Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized Clinical Trial. Guo L, JAMA network open	2026	Randomized trial	PMID 42234428 DOI	cites ClinicalTrials.gov:NCT05759897; registry reference DERIVED:42234428